https://www.selleckchem.com/pr....oducts/all-trans-ret
J Drugs Dermatol. 2022;21(5)529-530. doi10.36849/JDD.6559.Immunosuppression, as seen in solid organ transplant recipients, is highly associated with the development of keratinocyte carcinomas (KCs). Reducing the level of immunosuppression lowers the incidence of KCs but at the cost of increased potential morbidity and mortality. Recent studies have revealed a greater prevalence of HPV DNA, especially that of β-HPV, in KCs of immunocompromised patients compared to KCs of immunocompetent individuals. A prior report demonstrated
Like
Comment
Share
